Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study - Test2 - elhamkhani - TriplyDB

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

http://www.wikidata.org/entity/Q34420149

about

Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis MDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 Years Comparison and development of pyrazinamide susceptibility testing methods for tuberculosis in Thailand.Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain A joint cross-border investigation of a cluster of multidrug-resistant tuberculosis in Austria, Romania and Germany in 2014 using classic, genotyping and whole genome sequencing methods: lessons learnt.A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis.Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives.The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis.Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.Real-Time Sequencing of Mycobacterium tuberculosis: Are We There Yet?Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis.A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.

P2860

Q27004697-0B16F653-DE4C-4EED-B77D-0CE093F64365 Q27011264-87DEBB27-434A-4669-AAB2-ED2FADCE8769 Q28087770-242BCEDC-4F81-44B3-81AA-7CA38AD1E3E5 Q28551671-C19B57DD-C596-49B1-B973-AF6BA1703F17 Q30278824-961FD079-D584-4AFF-80CC-B70056F749A4 Q30374556-5E4E9BC8-6779-4B60-8EA6-800F763623DE Q33601686-7895B8FC-41E5-43B2-ACCB-EFC6D16A19E4 Q33812455-CD359C3B-99D6-4ED6-A00E-8AEA49181433 Q33896434-07F96085-EADD-426F-968D-02E7E5C245BC Q33912749-615CE300-CBAD-44CD-92EE-9F57C0E970F8 Q35076847-119CA8CB-C641-4069-8D6F-FD5F5A792B36 Q35743972-F5D390A7-11AD-487D-ACE5-542EE838B95F Q36019139-AD83B396-C61D-448E-A50D-1DC6CCC82FD2 Q36076037-DAC3AF7C-C98C-44E1-B948-52D3C5DB9D29 Q36084640-65F4AA87-219B-4F31-9987-EBF731D7B0E2 Q36174022-0CCC9718-5E69-40FA-BC07-CCFBC04792A9 Q36297624-540FC4D8-8344-49D6-8FF0-48BB8F480CFF Q36571981-FCDADA02-B4F7-4EB0-AD6E-37AE87534DFB Q37120038-96AEC3D2-4EA0-4E65-B68D-DA62B8115060 Q37133281-F39884A7-4648-4E3A-982C-A12B7B61A439 Q37229528-5DF68731-7D1A-48F8-968A-DCD8DA4C64C9 Q37270722-21CA33D4-4F5C-4A87-92BF-8916A6F3C687 Q37358689-886AD1F2-EC83-4CD1-BCF8-9732B308362C Q37739640-934DFC8A-F854-473B-AD36-B6A8805DD144 Q38368943-C5F0DAAA-9B54-4E19-AC4B-E4469049E62F Q38545953-A2D5A9D7-9F08-4C06-AF2B-03BBD8E9068E Q38674445-5F2A20C9-D2C4-4891-B2C9-F2AD0FF7CBDD Q38739933-FFFDA247-EC86-4F79-B8BC-56DA17DCCF4A Q38829192-2ED69EBC-CAD8-476C-A139-34E7F1302730 Q39785436-546BECA4-7048-40AF-8FC2-086C46CC3F91 Q40048055-901F44ED-5FF9-4CA8-ACB9-63C1141A3CF4 Q40290488-B2A48774-CF47-4CDE-9229-44C42964D122 Q40936781-82859902-78BF-4DA6-8E14-825D9DC2D454 Q41701192-A4805F07-6D70-4CB2-9BA5-7917D9F5A07D Q42278779-C4AB0093-170A-4D52-9EDC-68FB88438DC0 Q42618592-DFA74D42-7085-4B46-8995-2F70B6F5DA03 Q43923911-46339BD2-1698-41B0-BAFA-6CA7D44AF265 Q45223094-640A987C-F6B7-431C-A007-04207D882CF3 Q46319545-180D86E0-CFE8-4776-BB09-0247EAFA561A Q46683653-9D3A352A-EAFE-4F45-93C0-55C749EE7036

P2860

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

http://www.wikidata.org/entity/Q34420149

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@ast

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@en

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@nl

type

label

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@ast

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@en

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@nl

prefLabel

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@ast

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@en

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@nl

P1433

Q34420149-280364F8-50D0-4DC6-822B-3BD811DB48B6

P1476

Q34420149-9D9FEC57-43DA-4A52-9007-E607E7B8D2F1

P2093

Q34420149-28074028-6337-43CB-9771-0136453DC7AD

Q34420149-2F339580-B29B-47FE-A7CC-20C6D5CB92A1

Q34420149-51DD43DB-FF25-4397-B32E-2B64DDA88430

Q34420149-75158B60-F91B-4699-B770-D1F12FEF3913

Q34420149-854A63C8-E889-4EFF-97E0-2FEA750102DE

Q34420149-8C9E296E-404C-422B-B192-138846F1872B

Q34420149-957F2899-B869-4D69-8A45-E24A52B570CE

Q34420149-9D03A56C-5B12-4FD1-BCBC-FC56FBE9A9DB

Q34420149-A8F62591-0053-4A32-86F0-5D0E7FA3B9B9

Q34420149-B305A19C-885E-4F25-B9AF-53994D2F0EF3

P2860

Q34420149-097D818D-106C-41BE-87B2-A5A7060020CE

Q34420149-1B654145-0409-4F72-9F05-DDF6A49B6033

Q34420149-1B91F6A1-2324-47B7-A7C2-75DD36FEE235

Q34420149-1E7A3659-7CE0-4E05-B25F-C1E76E9C46D3

Q34420149-254B56D6-6DE5-4C2C-AC0C-25BC8FD79D4F

Q34420149-28E97091-51D0-4DA2-9377-E96B064D0A2B

Q34420149-294ABFF2-169C-4E0E-8735-C6901C6886FF

Q34420149-29824B8F-3C46-4870-B693-9027A3C0FA94

Q34420149-29B2F932-9A6A-4B0C-8432-A5E7D82C09F8

Q34420149-2F0AD291-5AC7-4209-A1B1-3ED052AA4A66

P304

Q34420149-A256B7EA-13F1-49B9-9CF9-704AF5CDBE73

P31

Q34420149-E30A622C-088E-42E5-8AD1-97B3261E16DF

P356

Q34420149-4CEBFED0-6F63-4113-8D8D-59EE9AF679CF

P433

Q34420149-C20F76C9-6304-4D6E-8859-110AF35C974C

P478

Q34420149-667BB5F6-0499-4110-8AC5-F59C7B0A588B

P50

Q34420149-36880204-73BD-4837-9249-DC762CE1CC83

Q34420149-7113E047-81C3-4815-AEDF-A437427D064A

Q34420149-8A7617BB-E024-44A5-82FC-0AE9EAB3F330

Q34420149-958C93BC-40E8-4020-BC2A-10F0DCA0670A

Q34420149-A036FCD9-7FF9-44B2-8DA3-9321F78D91BC

Q34420149-AB7D9165-21D3-4774-8369-1C7471D410A8

P577

Q34420149-F947D72A-58AE-4782-A247-7DA65A127FFF

P698

Q34420149-544BF513-3208-4604-BDB4-ADF55A978BEC

P921

Q34420149-1A0E1785-669A-40DE-B57B-0C98D5F06AE2

Q34420149-324620FA-197D-43FB-8BAB-930869FABE8C

P932

Q34420149-E545757C-A072-4025-B37B-F19E4A385616

P356

P1433

P1476

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study

@en

P2093

Daiva Bakonyte

http://www.w3.org/2001/XMLSchema#string

Daniela M Cirillo

http://www.w3.org/2001/XMLSchema#string

Edita Pimkina

http://www.w3.org/2001/XMLSchema#string

Jim Werngren

http://www.w3.org/2001/XMLSchema#string

Mikael Mansjö

http://www.w3.org/2001/XMLSchema#string

Nicola Casali

http://www.w3.org/2001/XMLSchema#string

Petras Stakenas

http://www.w3.org/2001/XMLSchema#string

Sabine Rüsch-Gerdes

http://www.w3.org/2001/XMLSchema#string

Silke Feuerriegel

http://www.w3.org/2001/XMLSchema#string

Stefan Niemann

http://www.w3.org/2001/XMLSchema#string

P2860

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide

Role of individual drugs in the chemotherapy of tuberculosis

Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans

Routine use of microbial whole genome sequencing in diagnostic and public health microbiology

Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations

Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.

Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates.

Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.

Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.

P304

e01819-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MBIO.01819-14

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Ambrosi

Andrea M. Cabibbe

Francis Drobniewski

Ewa Augustynowicz-Kopec

P577

2014-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25336456

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

multicenter trial

P932

4212837

http://www.w3.org/2001/XMLSchema#string